BONN, Germany.—Cardionovum GmbH announced today that it expects to launch in Europe in Q4 2012 a next-generation Sirolimus-eluting coronary stent system—PROLIMUS Biograde—which is designed to optimize ...
BONN, Germany--(BUSINESS WIRE)-- Cardionovum GmbH announced today that it has established its distribution network in 57 countries since the beginning of 2012. The Company is commercializing its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results